Making the Case for New Biomarker-based Assays
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read MorePosted by Chris Wolski | Apr 17, 2024 | Womens Health |
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read MorePosted by Andy Lundin | Apr 17, 2024 | Infectious Diseases |
Delve Bio announced data on the use of mNGS for the definitive diagnosis of infectious causes of meningitis and/or encephalitis.
Read MorePosted by Andy Lundin | Apr 12, 2024 | Emerging & Zoonotic Diseases |
The FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read MorePosted by Andy Lundin | Apr 11, 2024 | Urinalysis & Toxicology |
QuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MorePosted by Andy Lundin | Apr 5, 2024 | Cardiovascular |
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read More